Noticias de ACAD_US

Mercado

Noticias del mercado

Últimas noticias sobre ACAD_US — 136 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: ACAD_US ✕ 136 resultados
07/10/2026 ACAD_US — ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating ACADIA Pharmaceuticals Inc. (ACAD) And Encourages Stockholders to Connect

NEW YORK CITY, NY / ACCESS Newswire / October 5, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ACADIA ...

07/10/2026 ACAD_US — Yahoo Finance
ACADIA Pharmaceuticals Inc. (ACAD) Stock Forecasts

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

06/10/2026 ACAD_US — AD HOC NEWS
RBC keeps Outperform on ACADIA Pharmaceuticals stock at USD 37

Revenue reached USD 307.96 million in the second quarter of 2026, up 14.90 percent. ACADIA Pharmaceu

06/10/2026 ACAD_US — ad-hoc-news.de
RBC reiterates Outperform on ACADIA Pharmaceuticals stock

Revenue hit USD 308.0 million, up 16.00 percent year over year. ACADIA Pharmaceuticals stock costs E

03/10/2026 ACAD_US — ACCESS Newswire
ACADIA Pharmaceuticals Inc. (ACAD) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / October 2, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ACADIA ...

02/10/2026 ACAD_US — Yahoo Finance
ACADIA Pharmaceuticals Inc. (ACAD) Stock forecasts

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

02/10/2026 ACAD_US — AD HOC NEWS
Needham cuts target for ACADIA Pharmaceuticals stock from USD 40.00 to USD 35.00

Q2 revenue rose 16.40 percent to USD 308.00 million. ACADIA Pharmaceuticals stock costs EUR 17.86 ve

02/10/2026 ACAD_US — ad-hoc-news.de
Needham cuts target for ACADIA Pharmaceuticals stock from USD 40.00 to USD 35.00

Q2 revenue rose 16.40 percent to USD 308.00 million. ACADIA Pharmaceuticals stock costs EUR 17.86 ve

Página 3 de 7